Constellium N.V (NYSE:CSTM) marched up 82.24% compared to a 52-week low price of $5.35. The shares were last seen trading 6.56% higher, taking the closing price at $9.75 on 11/16/2017. At recent session, the prices were hovering between $9.6 and $10. This company shares are 21.95% off its target price of $11.89 and the current market capitalization stands at $1.27B. The recent change has given its price a -8.68% deficit over SMA 50 and -21.69% deficit over its 52-week high. The stock witnessed -10.55% declines, -3.47% declines and 54.76% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found CSTM’s volatility during a week at 5.33% and during a month it has been found around 5.14%.Constellium N.V (CSTM) Top Holders
Institutional investors currently hold around $549 million or 56.4% in CSTM stock. Look at its top three institutional owners. Vaughan Nelson Investment Management, L.P. owns $41.87 million in Constellium N.V, which represents roughly 3.3% of the company’s market cap and approximately 7.63% of the institutional ownership. Similar statistics are true for the second largest owner, Morgan Stanley, which owns 3,165,006 shares of the stock are valued at $28.96 million. The third largest holder is Anchorage Capital Group, L.L.C., which currently holds $28 million worth of this stock and that ownership represents nearly 2.2% of its market capitalization.Constellium N.V 13F Filings
At the end of 09/30/2017 reporting period, 76 institutional holders increased their position in Constellium N.V (NYSE:CSTM) by some 15,144,395 shares, 62 decreased positions by 16,177,892 and 18 held positions by 28,679,762. That puts total institutional holdings at 60,002,049 shares, according to SEC filings. The stock grabbed 34 new institutional investments totaling 8,421,100 shares while 18 institutional investors sold out their entire positions totaling 4,622,087 shares.Constellium N.V (CSTM) Analyst Guide
Several analysts have released their opinion on Constellium N.V (NYSE:CSTM), with 3 analysts believing it is a strong buy. Whereas 4 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2.14 average brokerage recommendation.